Authors/Disclosures
		
			| Kevin M. Biglan, MD
					(Eli Lilly) | Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly. | 
		
			| Michael D. Geschwind, MD, PhD, FAAN
					(UCSF) | Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			| Gail Kang, MD | No disclosure on file | 
		
			| Lynn A. Raymond, MD, PhD
					(University of British Columbia) | No disclosure on file | 
		
			| Claudia Testa, MD, PhD
					(University of North Carolina at Chapel Hill) | Dr. Testa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Testa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Dr. Testa has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Tremor Research Group. | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			| Jane S. Paulsen, PhD
					(University of Wisconsin, Madison) | Dr. Paulsen has received personal compensation in the range of $0-$499 for serving as a Consultant for CHDI. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for HDSA.  The institution of Dr. Paulsen has received research support from NIH/NIA.  The institution of Dr. Paulsen has received research support from NIH/NINDS. | 
		
			|  | No disclosure on file |